Financial Statements 10 Property, Plant and equipment land and Plant and buildings equipment Total m m m Cost At 1 January 2014 576 1,322 1,898 Additions 7 151 158 Disposals 30 50 80 Divested upon demerger 18 18 Reclassifications 22 22 Exchange adjustments 44 193 237 At 31 december 2014 531 1,190 1,721 Accumulated depreciation and impairment At 1 January 2014 224 913 1,137 Charge for the year 26 107 133 Disposals 20 41 61 Divested upon demerger 14 14 Exchange adjustments 39 192 231 At 31 december 2014 191 773 964 net book amount at 31 december 2014 340 417 757 Land and Plant and buildings equipment Total m m m Cost At 1 January 2013 525 1,285 1,810 Additions 28 172 200 Arising on business combination 1 4 5 Disposals 4 44 48 Reclassifications 46 46 Exchange adjustments 20 49 69 At 31 December 2013 576 1,322 1,898 Accumulated depreciation and impairment At 1 January 2013 205 869 1,074 Charge for the year 29 111 140 Disposals 4 35 39 Exchange adjustments 6 32 38 At 31 December 2013 224 913 1,137 Net book amount at 31 December 2013 352 409 761 The net book amount of assets under construction is 78m 2013: 60m.
Assets under construction are included within plant and equipment.
The reclassification from plant and equipment to land and buildings of 22m 2013: 46m shows the transfer of completed assets.
Capital expenditure which was contracted but not capitalised at 31 December 2014 was 27m 2013: 30m.
Included within the depreciation and impairment charge for the year is 1m 2013: 1m relating to the pharmaceutical business.
These amounts are included within Net Income from discontinued operations in the Group Income Statement.
RB Annual Report and Financial Statements 2014 93
